Atossa Therapeutics Staples One Contingent Value Right to Each Common Share

Bitget2026/10/19 12:16

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Atossa Therapeutics common stock will carry one stapled contingent value right (CVR) per share at the October 19, 2026, close of business.
CVRs will transfer only with their corresponding shares unless the board elects to detach them for separate trading.
Shares issued subsequently will also carry one attached CVR until detachment or expiration of the CVR Agreement.
Holders collectively will receive 25% of net proceeds from the first qualifying priority review voucher’s sale or deemed monetization, capped at $50 million.
CVRs cover the first qualifying voucher awarded by December 31, 2036, subject to a board extension.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF74933) on October 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Atossa Therapeutics Staples One Contingent Value Right to Each Common Share

You may also like

Crypto prices